Search results
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka· 2 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Gateway - Quartz
Quartz· 10 hours agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According ...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 18 hours agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 1 day agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 ...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 2 days agoCiting the 69-page lawsuit submitted to the District Court of Thomas County, Fox Business highlights that Pfizer misled the public by claiming its COVID ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 2 days agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit
Reuters· 2 days ago, opens new tab filed in the District Court of Thomas County, the state said the New York-based drugmaker's alleged false statements violated the Kansas Consumer Protection Act. "Pfizer ...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
US News & World Report· 5 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the ...